Business
GPT Healthcare Limited (“the Company”) is engaged in the Healthcare Services i.e running of hospitals and providing medical services. We operate a chain of mid-sized full service hospitals under the brand name of “ILS Hospitals” and provide integrated healthcare services, with a focus on secondary and tertiary care. As of March 31, 2024, we operate four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of 561 beds.
Annual General Meeting
2024
| Date of Annual General Meeting : | Thursday, July 25, 2024 at 3.00 P.M. (IST) through Video Conferencing and Other Audio-Visual Means (“VC/OAVM”) |
| Mode of Meeting (Place) : | To be held through Video Conferencing (VC) Mode. |
| Book Closure : | The Register of Members and Share Transfer Books of the Company will remain closed from Friday, July 19, 2024 to Thursday, July 25, 2024 (both days inclusive) |
| Record (Cut Off) Date | Thursday, July 18, 2024 |
| Remote e-Voting | The remote e-voting period commences on Monday, July 22, 2024 (at 9.00 a.m. IST) and ends on Wednesday, July 24, 2024 (at 5.00 p.m. IST). |
| Particulars | Download |
|---|---|
| Voting Results and Scrutinizer Report on 35th Annual General Meeting |
|
| Proceedings of the 35th Annual General Meeting of the Company |
|
| Notice of 35th Annual General Meeting of the Company |
|
| Intimation regarding the 35th Annual General Meeting, Dividend & Book Closure and Record date |
|
| Newspaper Publication of Pre Despatch of AGM Notice |
|
| Newspaper Publication of Post Despatch of AGM Notice |
|
2023
Date of AGM:
Place:
Book Closure:
Cut off Date:
Remote e-Voting:
Particulars
Download
AGM voting Results along with scrutiniser Report
Proceedings of the 35th AGM of the Company
Notice of the 35th AGM along with intimation of Book Closure
AGM Notice after Dispatch
News Paper Advertisement
| Date of AGM: | |
| Place: | |
| Book Closure: | |
| Cut off Date: | |
| Remote e-Voting: |
| Particulars | Download |
|---|---|
| AGM voting Results along with scrutiniser Report | |
| Proceedings of the 35th AGM of the Company | |
| Notice of the 35th AGM along with intimation of Book Closure | |
| AGM Notice after Dispatch | |
| News Paper Advertisement | |
Postal Ballot
| Particulars | Download |
|---|---|
| Postal Ballot Notice |
|
| News paper Notice for Postal Ballot and E-voting |
|
| Scrutinizer Report | |
| Postal Ballot Result | |
Shareholding Pattern
| Financial Year | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| 2024-2025 | |
|
NA | NA |
| 2023 - 2024 | NA | NA | NA | |
Share Capital
| Authorised Share Capital | Rs. 125,00,00,000 Divided into 12,50,00,000 Equity Shares of Rs. 10/- Each. |
| Issued, Paid-Up & Subscribed Capital | Rs. 82,05,48,230 Divided into 8,20,54,823 Equity Shares of Rs. 10/- Each. |
Earnings Call
| Quarter | Earnings Presentation | Call Invite | Earnings Call Transcript |
|---|---|---|---|
| Q2 : 2024-25 |
Investor Presentations |
Intimation of Earnings Call |
GHL Conference Call 14.11.2024 |
| Q1 : 2024-25 |
Investor Presentations |
GHL-Intimation of Earnings Calls |
GHL-Call Transcript 14.08.2024 |
| Q4 : 2023-24 | Investor Presentations |
GHL-Intimation of Earnings Calls 14.05.2024 |
GHL-Call Transcript 22.05.2024 |
| Q3 : 2023-24 | Investor Presentations |
GHL-Intimation of Earnings Calls 18.03.2024 |
GHL-Call Transcript 23.03.2024 |
| Q2: 2023-24 | NA | NA | NA |
| Q1: 2023-24 | NA | NA | NA |
Dividend
Details of Dividend declared and the respective due dates for transfer of theunclaimed/unpaid dividend to IEPF as on 31.03.2024:
| Dividend for the Financial Year | Date of declaration of Dividend | Type of Dividend | Amount of Dividend declared | Rate of dividend (%) | Due date of Transfer to IEPF | Remarks |
|---|---|---|---|---|---|---|
| 2024-25 | 14.11.2024 | Interim Dividend | 8,20,54,823 | 10% (Rs. 1.00 per share) | 20.12.2031 | - |
| 2023-24 | 05.01.2024 | Interim Dividend | 7,99,04,286 | 10% (Rs. 1.00 per share) | 10.01.2031 | No Unpaid Dividend |
| 19.03.2024 | Interim Dividend | 8,20,54,823 | 10% (Rs. 1.00 per share) | 24.04.2031 | - | |
| 25.07.2024 | Final Dividend | 12,30,82,234.50 | 15% (Rs. 1.50 per share) | 30.08.2031 | - |
Unpaid Dividend
There are no unclaimed and unpaid amount pending with company till 31.03.2024.
Corporate Presentation
| Particulars | Download |
|---|---|
| Corporate Presentation 2024 |
|
Corporate Policies
| Policy Document | Download |
|---|---|
| GHL-Board Performance Appraisal Policy | |
| GHL-Code of Conduct for Board and Senior Mangers | |
| GHL-Code of Conduct for Prevention of Insider Trading | |
| GHL-Code of Corporate Disclosure for PIT | |
| GHL-Criteria for making payment to Non Executive Directors | |
| GHL-CSR Policy | |
| GHL-Diversity Policy | |
| GHL-Dividend Policy | |
| GHL-Familiarisation Programme for IDs | |
| GHL-Materiality Policy for Disclosure in Offer Documents | |
| GHL-Materiality Subsidiary Policy | |
| GHL-Nomination and Remuneration Policy | |
| GHL-Policy for Determining Materiality for Disclosure | |
| GHL-Policy for Document Retention and Archival | |
| GHL-Policy on Succession Planning | |
| GHL-Related Party Transactions Policy | |
| GHL-Risk Management Policy | |
| GHL-Sexual Harassment Policy | |
| GHL-Terms of Appointment of Independent Director | |
| GHL-Vigil Mechanism Policy | |
Compliances
Related Party Transactions
| Compliances Document | Link |
|---|---|
| Related Party Transactions | https://www.bseindia.com/stock-share-price/rpt/scripcode/544131/flag/7/ |
Compliance under Regulation 74(5) of the SEBI (DP) Regulations, 2018
| Compliances Document | Download |
|---|---|
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E September 30, 2024 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E June 30, 2024 | |
| Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2024 | |
Compliance under Reg. 13(3) of Listing Regulations
| Compliances Document | Download |
|---|---|
| Investor Compliant for the Q.E 30.09.2024 XBRL |
|
| Investor Compliant for the Q.E 30.06.2024 XBRL |
|
| Investor Compliant for the Q.E 31.03.2024 XBRL |
|
Reconciliation of Share Capital Audit
| Compliances Document | Download |
|---|---|
| Reconciliation of Share Capital Audit 30.09.2024 | |
| Reconciliation of Share Capital Audit 30.06.2024 | |
| Reconciliation of Share Capital Audit 31.03.2024 | |
Compliance under Reg. 32 of Listing Regulations
| Compliances Document | Download |
|---|---|
| Statement Of Deviation For The Quarter Ended March 31, 2024 | |
Compliance under Reg. 40(9) of Listing Regulations
| Compliances Document | Download |
|---|---|
| Certificate pursuant to Regulation 40(9) & (10) of the SEBI (LODR), Regulations, 2015 for the Q.E March 31, 2024 | |
Compliance under Reg. 7(3) of Listing Regulations
| Compliances Document | Download |
|---|---|
| Compliance Certificate under reg 7(3) of the SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024. |
|
Notices
| Type | Subject | Financial Year | Details | Download |
|---|---|---|---|---|
| Record Date | Record Date Notice for Dividend | 2024-25 | First Interim Dividend for FY 2024-25 | Record Date |
| Board Meeting Notice | Intimation of Board Meeting to be held on November 14, 2024 | 2024-25 | Approval of Un-Audited FR for the Q2 and Half year ended September 30, 2024 | GHL Intimation of Board Meeting |
| Board Meeting Notice | Intimation of Board Meeting to be held on August 13, 2024 | 2024-25 | Approval of Un-Audited FR for the Q1 ended June 30, 2024 | GHL Intimation of Board Meeting |
| Board Meeting Notice | Intimation of Board Meeting to be held on May 21, 2024 | 2024-25 | Approval of FR for the Q4 and Year ended March 31, 2024 | GHL-Intimation of Board Meeting |
| AGM, Book Closure Record date | Record Date Notice for Dividend | 2023-24 | Intimation regarding the 35th AGM, Dividend & Book Closure and Record date | GHL-AGM, Record Date and Book Closure |
| Board Meeting Notice | Intimation of Board Meeting to be held on March 19, 2024. | 2023-24 | Approval of UFR for the Q3 9M ended December 31, 2023 | GHL-Notice of Board Meetings |
| Record date | Record Date Notice for Dividend | 2023-24 | Second Interim Dividend | GHL-Revised Record Date Notice |
Disclosure Information
| Date | Document | Download |
|---|---|---|
| 21.11.2024 | Update on Conference Call held on November 14, 2024 - Call Transcript | |
| 19.11.2024 | Update on Conference Call held on November 14, 2024 - Call Transcript | |
| 19.11.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 16.11.2024 | Newspaper Publication of Q2FY25 Financial Results | |
| 14.11.2024 | Press Release on the Un-Audited Financial Results for the quarter ended September 30, 2024 | |
| 14.11.2024 | Investor Presentation for the quarter ended September 30, 2024 | |
| 14.11.2024 | Outcome of Board Meeting held on November 14, 2024 | |
| 14.11.2024 | Submission of Un-Audited Financial Results for the Quarter ended September 30, 2024 | |
| 14.11.2024 | Declaration of First Interim Dividend and Notice of Record Date | |
| 06.11.2024 | Intimation of Earnings Call to discuss the financial performance of the Company for the 2nd quarter and half year ended September 30, 2024 (Q2FY25). | |
| 04.11.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 04, 2024. | |
| 14.10.2024 | Reconciliation of Share Capital Audit 30.09.2024 | |
| 14.10.2024 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | |
| 27.09.2024 | Closure of Trading Window | |
| 29.08.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 22.08.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 16.08.2024 | Update on Conference Call held on August 14, 2024 – Call Transcript | |
| 14.08.2024 | Audio Recording of Q1 Earnings call held today i.e August 14, 2024 | |
| 14.08.2024 | Newspaper Publication of Q1FY25 Financial Results | |
| 13.08.2024 | Outcome of Board Meeting held on August 13, 2024 | |
| 13.08.2024 | Submission of Un-Audited Financial Results for the Quarter ended June 30, 2024 | |
| 13.08.2024 | Investor Presentation for the quarter ended June 30, 2024 | |
| 13.08.2024 | Press Release on the Un-Audited Financial Results for the quarter ended June 30, 2024 | |
| 07.08.2024 | Intimation of Earnings Call to discuss the financial performance of the Company for the 1st quarter ended June 30, 2024 (Q1FY25). | |
| 07.08.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on August 13, 2024. | |
| 26.07.2024 | Voting Results and Scrutinizer Report on 35th Annual General Meeting | |
| 25.07.2024 | Outcome and Proceeding of the 35th Annual General Meeting of the Company. | |
| 16.07.2024 | Reconciliation of Share Capital Audit 30.06.2024 | |
| 15.07.2024 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | |
| 04.07.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 02.07.2024 | Newspaper Publication of Post Despatch of AGM Notice | |
| 01.07.2024 | Submission of Notice of Annual General Meeting on Thursday, July 25, 2024 | |
| 01.07.2024 | Submission of Annual Report including Notice of 35th AGM | |
| 26.06.2024 | Closure of Trading Window | |
| 25.06.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 25.06.2024 | Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Execution of Agreements | |
| 25.06.2024 | Newspaper Publication of Pre Despatch of AGM Notice | |
| 20.06.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 14.06.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 29.05.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 29.05.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 27.05.2024 | Update on Conference Call held on May 22, 2024– Call Transcript | |
| 23.05.2024 | Newspaper Publication of Q4FY24 Financial Results | |
| 23.05.2024 | Filing of Secretarial Compliance Report for the year ended March 31, 2024 | |
| 22.05.2024 | Audio Recording of Q4 Earnings call held today i.e May 22, 2024 | |
| 21.05.2024 | Change in Directorate | |
| 21.05.2024 | Statement Of Deviation For The Quarter Ended March 31, 2024 | |
| 21.05.2024 | Outcome of Board Meeting held on May 21, 2024 | |
| 21.05.2024 | Submission of Results for the Q4 and Year ended March 31, 2024 | |
| 21.05.2024 | Press Release for the Q4 and Year ended March 31, 2024 | |
| 21.05.2024 | Submission of Investors Presentation Q4 FY2024 | |
| 21.05.2024 | Details of 35th Annual General Meeting, Book Closure Date and Record Date for Dividend | |
| 14.05.2024 | Intimation of Earnings Call to discuss the financial performance of the Company for the 4th quarter and year ended March 31, 2024. | |
| 14.05.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on May 21, 2024 | |
| 14.05.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on May 21, 2024 | |
| 10.05.2024 | Disclosure of Postal Ballot Results along with Scrutinizer Report | |
| 09.05.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 26.04.2024 | Intimation regarding change of Corporate Identification Number ("CIN") of GPT Healthcare Limited ("The Company") | |
| 25.04.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 25.04.2024 | Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Execution of Lease Agreement | |
| 24.04.2024 | Compliance Certificate under reg 7(3) of the SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024 | |
| 24.04.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 20.04.2024 | Resignation of Dr. Bharbi Chattopadhayay, SMP | |
| 16.04.2024 | Certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for Q.E March 31, 2024 | |
| 16.04.2024 | Certificate pursuant to Regulation 40(9) & (10) of the SEBI (LODR), Regulations, 2015 for the Q.E March 31, 2024 | |
| 16.04.2024 | Fund raising by issuance of debt securities by Large Entities | |
| 16.04.2024 | Reconciliation of Share Capital Audit Report for the quarter ended March 31, 2024. | |
| 12.04.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 09.04.2024 | Newspaper Publication of Postal Ballot Notice | |
| 08.04.2024 | Notice of Postal Ballot | |
| 28.03.2024 | Closure of Trading Window | |
| 23.03.2024 | Transcript of Conference Call held on Thursday, March 21, 2024. | |
| 21.03.2024 | Revision of Outcome of Board Meeting held on March 19, 2024 | |
| 21.03.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 | |
| 21.03.2024 | Audio Recording of Q3 Earnings call held today i.e March 21, 2024 | |
| 20.03.2024 | Newspaper Publication of Q3 Financial Results and Notice of Record Date | |
| 19.03.2024 | Revised Notice of Record Date | |
| 19.03.2024 | Submission of Investors Presentation Q3FY24 | |
| 19.03.2024 | Intimation in terms of Regulation 30(5) of the SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015. | |
| 19.03.2024 | Press Release on Q3 FY 2024 Financial Results | |
| 19.03.2024 | Declaration of Second Interim Dividend and Notice of Record Date | |
| 19.03.2024 | Submission of Un-AuditedFinancial Results for theQuarter and Nine Months ended December 31, 2023 | |
| 19.03.2024 | Outcome of Board Meeting held on March 19, 2024. | |
| 18.03.2024 | Intimation of Earnings Call to discuss the financial performance of the Company for the 3rd quarter ended December 31, 2023 | |
| 17.03.2024 | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | |
| 12.03.2024 | Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI(LODR), Regulations 2015 | |
| 11.03.2024 | Intimation of Board Meeting pursuant to Regulations 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on March 19, 2024. | |
| 02.03.2024 | Closure of Trading Window | |
Secretarial Compliance Report
| Date | Documents | Download |
|---|---|---|
| 31.03.2024 | Secretarial Compliance Report for the year ended March 31, 2024 | |
Annual Return
| Documents | Download |
|---|---|
| MGT-7 (Annual Return)- 2023-24 | |
| MGT-7 (Annual Return)- 2022-23 | |
| MGT-7 (Annual Return)- 2021-22 | |
| MGT-7 (Annual Return)- 2020-21 | |
Code of conduct
| Documents | Download |
|---|---|
| Code of conduct |
|
Reports on Corporate Governance
| Financial Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2024-25 | |
|
NA | NA |
| 2023-24 | NA | NA | NA |
|
Credit Rating
The long term and short term credit facilities are rated by CRISIL and the present rating of the Company is CRISIL A-/Stable (Reaffirmed)-Long Term Rating and CRISIL A2+ (Reaffirmed)-Short Term Rating on July 29, 2024.
Committees of the Board
Audit Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Deepak Pramanik | Chairman | Non-Executive – Independent Director |
| 2 | Mr. Kashi Prasad Khandelwal | Member | Non-Executive – Independent Director |
| 3 | Mr. Amrendra Prasad Verma | Member | Non-Executive – Independent Director |
Stakeholders Relationship Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Hari Modi | Chairman | Non-Executive Independent Director |
| 2 | Dr. Tapti Sen | Member | Non-Executive Independent Director |
| 3 | Mr. Anurag Tantia | Member | Whole-time Director |
Nomination and Remuneration Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Kashi Prasad Khandelwal | Chairman | Non-Executive – Independent Director |
| 2 | Dr. Tapti Sen | Member | Non-Executive – Independent Director |
| 3 | Mr. Hari Modi | Member | Non-Executive – Independent Director |
Corporate Social Responsibility Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Dwarika Prasad Tantia | Chairman | Chairman & Whole-time Director |
| 2 | Dr. Aruna Tantia | Member | Non-Executive – Non-Independent Director |
| 3 | Dr. Tapti Sen | Member | Non-Executive – Independent Director |
Risk Management Committee
| Sl No. | Name | Position | Category |
|---|---|---|---|
| 1 | Mr. Amrendra Prasad Verma | Chairman | Non-Executive – Independent Director |
| 2 | Mr. Kashi Prasad Khandelwal | Member | Non-Executive – Independent Director |
| 3 | Mr. Anurag Tantia | Member | Whole-time Director |
| 4 | Mrs Kriti Tantia | Permanent Invitee | CFO |
Board of Directors
Mr. Dwarika Prasad Tantia
Designation: Executive Chairman (KMP)
Dr. Om Tantia
Designation: Managing Director (KMP)
Dr. Aruna Tantia
Designation: Non-Executive Director
Dr. Ghanshyam Goyal
Designation: Non-Executive Director
Mr. Anurag Tantia
Designation: Executive Director (KMP)
Mr. Kashi Prasad Khandelwal
Designation: Independent Director
Mr. Amrendra Prasad Verma
Designation: Independent Director
Mr. Deepak Pramanik
Designation: Independent Director
Dr. Tapti Sen
Designation: Independent Director
Mr. Hari Modi
Designation: Independent Director
Stock Information
Listing Information
"The equity shares of GPT Healthcare Limted is listed on National Stock
Exchange of India Limited and BSE Limited. w.e.f. February 29, 2024"
National Stock Exchange (NSE)
Exchange Plaza, C-1, Block G Bandra Kurla Complex Bandra (E)
Mumbai 400 051
The Bombay Stock Exchange Limited (BSE)
Phiroze Jeejeebhoy Towers Dalal Street
Mumbai 400 001
| Stock Code | |
|---|---|
| BSE Scrip Code | 544131 |
| NSE Scrip Code | GPTHEALTH |
Changes in the company name
Our Company was originally incorporated as "Jibansatya Printing House Private Limited", a private limited company under the Companies Act, 1956 on August 17, 1989 at Kolkata, West Bengal. The name of our Company was subsequently changed to "GPT Healthcare Private Limited" on March 31, 2005. Thereafter, our Company was converted to a public limited company and our name was changed to "GPT Healthcare Limited on September 15, 2021.
Financials
Quarterly Results
| 2024 - 2025 | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| Standalone |
|
|
NA | NA |
Quarterly Results
| 2023 - 2024 | Q 1 | Q 2 | Q 3 | Q 4 |
|---|---|---|---|---|
| Standalone | NA | NA | |
|
Annual Reports
Downloads
| Form | Download-Form(pdf) | Purpose |
|---|---|---|
| Form ISR-1 | Request Form for Registering |
Request for Registering PAN, KYC details OR Changes/updations there of (only for securities held in physical) |
| Form ISR-2 | Bank Verification for Sign |
Confirmation of Signature of securities holder by Banker |
| Form ISR-3 | ISR-3 Opt Out |
Declaration for Opting-out of Nomination by holders of physical securities in Listed Companies |
| Form SH-13 | SH-13 Registration of Nominationn |
Nomination Form |
| Form SH-14 | Cancellation OR Variation of Nomination |
Cancellation OR Variation of Nomination |
Contact
Investor Relations/
Grievance Redressal/
Nodal Officer for IEPF
Company Secretary & Compliance Officer
GPT Healthcare Limited
Mr. Ankur Sharma
GPT Centre, JC-25, Sector-III
Salt Lake, Kolkata - 700 106
+91 33 4050 7000
ghl.cosec@gptgroup.co.in
Registrar & Share Transfer Agent
MUMBAI
Link Intime India Pvt. Ltd.
C-101, 247 Park,
LBS MARG, Vikhroli (West)
Mumbai - 400083
+91 22 49186200
gpthealthcare.ipo@linkintime.co.in
KOLKATA
Link Intime India Pvt. Ltd.
Rasoi Court, 5th floor
20, Sir R N Mukherjee Road,
Kolkata – 700001
033-4073 1698
kolkata@linkintime.co.in